Abstract:Background: In clinical practice, treatment recommendations and the patient’s wishes often diverge, facing the physician with difficult choices. Case Report: The clinical course of a 36-year-old patient with ‘platinum-refractory’ ovarian cancer is reported. The patient experienced a symptomatic relapse 7 months after debulking surgery and completion of platinum-based first-line chemotherapy. As she had given birth to a son 22 months before diagnosis, she fought with outmost determination against her disease. H… Show more
“…Quality of life and balancing the impact of cancer treatment is an area of great discussion and debate, with both clinical and academic interest [1][2][3]. There have been numerous articles, books and psychological studies examining the role of personality, affect regulation and social support factors in determining outcomes from cancer treatment [4][5].…”
Background: The balance between quality of life and aggressive
treatment fuels strong debate in cancer care.
Recently, more attention is focused on blending advanced
care, palliative care and hospice treatments in a
patient-specific, tailored manner. This case study explores
quality of life, the role of psychosocial factors in
treatment selection, and the role of medical bias in endof-
life decision-making. Case Report: The patient was a
55-year-old woman with advanced recurrent epithelial
ovarian cancer. The disease course was essentially unremitting
with only 5 months of non-progression after
initial treatment. Multiple courses of chemotherapy were
provided, in addition to a wide range of advanced and
aggressive therapies to treat the cancer, as well as prolong
life. Hospice care was an active part of treatment
over 2 separate time periods, with a 1-year hiatus between
admissions into hospice care. Conclusion: This
case study provides an example of blending aggressive
treatment, palliative care and hospice care to allow a patient
to achieve specific life milestones, while attempting
to preserve quality of life.
“…Quality of life and balancing the impact of cancer treatment is an area of great discussion and debate, with both clinical and academic interest [1][2][3]. There have been numerous articles, books and psychological studies examining the role of personality, affect regulation and social support factors in determining outcomes from cancer treatment [4][5].…”
Background: The balance between quality of life and aggressive
treatment fuels strong debate in cancer care.
Recently, more attention is focused on blending advanced
care, palliative care and hospice treatments in a
patient-specific, tailored manner. This case study explores
quality of life, the role of psychosocial factors in
treatment selection, and the role of medical bias in endof-
life decision-making. Case Report: The patient was a
55-year-old woman with advanced recurrent epithelial
ovarian cancer. The disease course was essentially unremitting
with only 5 months of non-progression after
initial treatment. Multiple courses of chemotherapy were
provided, in addition to a wide range of advanced and
aggressive therapies to treat the cancer, as well as prolong
life. Hospice care was an active part of treatment
over 2 separate time periods, with a 1-year hiatus between
admissions into hospice care. Conclusion: This
case study provides an example of blending aggressive
treatment, palliative care and hospice care to allow a patient
to achieve specific life milestones, while attempting
to preserve quality of life.
Themes included the education of health care providers, the need to care for carers, and interdisciplinary communication. Little attention was given to the growing population of elderly patients. Observer-based studies are unfortunately scarce, making the practice of palliative communication unseen. Finally, few studies report the cost-effectiveness of palliative care interventions though such studies may enhance palliative care and convince policy makers of the need to support such care. More empirical work is needed to improve the level of quality needed to ensure a good remaining lifetime for cancer patients whose disease cannot be cured.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.